International Journal of Oral Biology

  • 제39권3호
  • /
  • Pages.153-157
  • /
  • 2014
  • /
  • 1226-7155(pISSN)
  • /
  • 2287-6618(eISSN)
대한구강생물학회 (The Korean Academy of Oral Biology)
권호 표지
DOI QR코드

DOI QR Code

Comparative Evaluation of Fibrin for Bone Regeneration in Critical Size Calvarial Defects

  • Song, Gin-Ah (Department of Molecular Genetics, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Kim, Soung Min (Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University) ;
  • Woo, Kyung Mi (Department of Molecular Genetics, Dental Research Institute, School of Dentistry, Seoul National University)
  • 투고 : 2014.08.08
  • 심사 : 2014.08.26
  • 발행 : 2014.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Natural biopolymers such as collagen and fibrin have been widely used in bone regenerative applications. Despite the frequent use, their comparative biological propertiesis are largely unknown. In a previous study, we found the superiority of fibrin to collagen in the adsorption of serum proteins and the proliferation and differentiation of cultured osteoblasts. In this study, we used an in vivo model to evaluate how effectively fibrin supports bone regeneration, as compared with collagen. Collagen and fibrin were placed in critical size defects made on rat calvarial bones. Compared with collagen, fibrin supported substantially more new bone tissue formation, which was confirmed by micro-CT measurement and histological analyses. The cells in the regenerative tissues of the fibrin-filled defects were immunostained strongly for Runx2, while collagen-placed defects were stained weakly. These in vivo results demonstrate that fibrin is superior to collagen in supporting bone regeneration.

키워드

참고문헌

  1. Lynch MP, Stein JL, Stein GS, Lian JB. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res. 1995:216:35-45. https://doi.org/10.1006/excr.1995.1005
  2. Mizuno M, Fujisawa R, Kuboki Y. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction. J Cell Physiol. 2000;184:207-213. https://doi.org/10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.0.CO;2-U
  3. Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci. 1997;110: 2187-2196.
  4. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem. 2000;275:35-40. https://doi.org/10.1074/jbc.275.1.35
  5. Oh JH, Seo J, Yoon WJ, Cho JY, Baek JH, Ryoo HM, Woo KM. Suppression of Runx2 protein degradation by fibrous engineered matrix. Biomaterials 2011;32:5826-5836. https://doi.org/10.1016/j.biomaterials.2011.04.074
  6. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res. 2002;60:613-621. https://doi.org/10.1002/jbm.10167
  7. Woo KM, Jun JH, Chen VJ, Seo J, Baek JH, Ryoo HM, Kim GS, Somerman MJ, Ma PX. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials 2007;28:335-343. https://doi.org/10.1016/j.biomaterials.2006.06.013
  8. Ma PX. Biomimetic materials for tissue engineering. Adv Drug Delivery Rev 2008;60:184-198. https://doi.org/10.1016/j.addr.2007.08.041
  9. Breen A, O'Brien T, Pandit A. Fibrin as a Delivery System for Therapeutic Drugs and Biomolecules. Tissue Eng Part B-Re. 2009;15:201-214.
  10. Amrani DL, Diorio JP, Delmotte Y. Wound healing. Role of commercial fibrin sealants. Ann N Y Acad Sci. 2001;936:566-579.
  11. Clark RA. Fibrin is a many splendored thing. J Invest Dermatol. 2003;121:xxi-xxii. https://doi.org/10.1046/j.1523-1747.2003.12575.x
  12. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:11-30.
  13. Alston SM, Solen KA, Sukavaneshvar S, Mohammad SF. In vivo efficacy of a new autologous fibrin sealant. J Surg Res. 2008;146:143-148. https://doi.org/10.1016/j.jss.2007.08.006
  14. Flanagan TC, Cornelissen C, Koch S, Tschoeke B, Sachweh JS, Schmitz-Rode T, Jockenhoevel S. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 2007;28:3388-3397. https://doi.org/10.1016/j.biomaterials.2007.04.012
  15. Oh JH, Kim HJ, Kim TI, Woo KM. Comparative evaluation of the biological properties of fibrin for bone regeneration. BMB Rep. 2014;47:110-114. https://doi.org/10.5483/BMBRep.2014.47.2.156
  16. Jung HM, Song GA, Lee YK, Baek JH, Ryoo HM, Kim GS, Choung PH, Woo KM. Modulation of the resorption and osteoconductivity of alpha-calcium sulfate by histone deacetylase inhibitors. Biomaterials 2010;31:29-37. https://doi.org/10.1016/j.biomaterials.2009.09.019
  17. Oh JH, Kim HJ, Kim TI, Baek JH, Ryoo HM, Woo KM. The effects of the modulation of the fibronectin-binding capacity of fibrin by thrombin on osteoblast differentiation. Biomaterials 2012;33:4089-4099. https://doi.org/10.1016/j.biomaterials.2012.02.028
  18. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361. https://doi.org/10.1161/01.ATV.20.5.1354
  19. Davis HE, Miller SL, Case EM, Leach JK. Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response. Acta Biomater. 2011;7:691-699. https://doi.org/10.1016/j.actbio.2010.09.007
  20. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764. https://doi.org/10.1016/S0092-8674(00)80258-5
  21. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS. Expression and regulation of Run$\times$2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem. 2001;80:424-440. https://doi.org/10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6
  22. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem. 1999;73: 114-125. https://doi.org/10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.0.CO;2-M
  23. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res. 2002;17:101-110. https://doi.org/10.1359/jbmr.2002.17.1.101